PPARG and cancer: In this regard, cancer-derived miRNA-27 may suppress PPARγ and C/EBPα expression and may induce their change of phenotype into CAAs, in CRC cases [29,46], while a miRNA-27b-3p overexpression has been accompanied by an inhibition of browning in WAT [47].